Which has the lower trailing P/E, GMED or OSCR?

GMED has the lower trailing P/E: GMED trades at 20.74 and OSCR at 21.66. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or OSCR?

Over the past five years, OSCR grew revenue faster — GMED at a 27.65% CAGR versus OSCR at 64.83%.

Is GMED or OSCR more profitable?

GMED runs the higher net margin — GMED at 17.03% versus OSCR at 3.60%.

How have GMED and OSCR total returns compared?

Over the past 5 years, GMED delivered 12.90% and OSCR delivered 10.67% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Globus Medical, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$10.54B

$78.12HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT

OSCR

Oscar Health, Inc.

$8.36B

$32.24HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT

Total return — GMED vs OSCR

growth of $100 · dividends reinvested · last 6y

GMED +29.5% (+4.4%/yr)OSCR -12.8% (-2.3%/yr)GMED compounded faster over this window

GMED OSCR

GMED vs OSCR: by the numbers

•GMED is the larger company ($10.54B vs $8.36B market cap).
•GMED trades at the lower trailing earnings multiple (20.74 vs 21.66 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 3.60% net margin).
•OSCR grew revenue faster over the past five years (64.83% vs 27.65% CAGR).

Metrics side by side

Valuation

Metric	GMED	OSCR
P/E ratio	20.74	21.66
Forward P/E	16.13	17.59
P/S ratio	3.54	0.66
P/B ratio	2.34	4.93
EV / EBITDA	11.52	9.92
FCF yield	6.73%	42.92%

Profitability

Metric	GMED	OSCR
Gross margin	68.55%	14.38%
Operating margin	20.75%	4.07%
Net margin	17.03%	3.60%
ROE	11.23%	26.84%
ROIC	10.49%	22.98%

Growth (annualized)

Metric	GMED	OSCR
Revenue CAGR (5Y)	27.65%	64.83%
EPS CAGR (5Y)	30.79%	N/A
FCF CAGR (5Y)	29.93%	80.81%
Total return CAGR (5Y)	-0.76%	10.67%

Frequently asked

Which has the lower trailing P/E, GMED or OSCR?: GMED has the lower trailing P/E: GMED trades at 20.74 and OSCR at 21.66. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or OSCR?: Over the past five years, OSCR grew revenue faster — GMED at a 27.65% CAGR versus OSCR at 64.83%.
Is GMED or OSCR more profitable?: GMED runs the higher net margin — GMED at 17.03% versus OSCR at 3.60%.
How have GMED and OSCR total returns compared?: Over the past 5 years, GMED delivered 12.90% and OSCR delivered 10.67% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full OSCR analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Oscar Health P/E ratio Globus Medical ROE Oscar Health ROE Globus Medical operating margin Oscar Health operating margin Globus Medical revenue growth Oscar Health revenue growth Globus Medical free cash flow Oscar Health free cash flow

Globus Medical & Oscar Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.